Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

September 19, 2019

Primary Completion Date

August 30, 2027

Study Completion Date

March 30, 2028

Conditions
Chagas Disease
Interventions
DRUG

Benznidazole

Drug: Benznidazole Tablets 100 mg (functionally scored) or Tablets 12.5 mg

Trial Locations (9)

Unknown

"Hospital de Ninos Dr. Ricardo Gutierrez", Buenos Aires

"Hospital Luis Carlos Lagomaggiore", Mendoza

"Hospital Pediatrico Dr. Humberto Notti", Mendoza

Hospital Público Descentralizado Dr. Guillermo Rawson, San Juan

Centro de Enfermedad de Chagas y Patologías Regionales, Santiago del Estero

Antigua Hospital Viedma, Cochabamba

CEADES - Plataforma de Chagas Sucre, Sucre

Fundación Salud para el Trópico, Santa Marta

Centro de Atención e Investigación Médica (CAIMED), Yopal

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Chemo Research

INDUSTRY

lead

Insud Pharma

INDUSTRY

NCT04024163 - Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease | Biotech Hunter | Biotech Hunter